Advertisement

Reactions Weekly

, Volume 1771, Issue 1, pp 91–91 | Cite as

Ciclosporin/methotrexate/mycophenolate mofetil

Epstein-Barr virus associated post-transplant lymphoproliferative disorder: 27 case reports
Case report
  • 31 Downloads

Reference

  1. Zhu CY, et al. Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience. Annals of Transplantation 24: 175-184, 2019. Available from: URL: http://doi.org/10.12659/AOT.914101 - China

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations